Polyclonal Antibodies
Anti-MT-ATP6 Polyclonal Antibody for WB, IF/ICC, IHC-P, ELISA - P00846
Item Number : CM0021705
Price varies based on specs and customizations
- Application
- WB, IF/ICC, IHC-P, ELISA
- Cross Reactivity
- Human, Mouse, Rat
- Protein Weight
- 25 kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | MT-ATP6 Rabbit pAb |
| Remarks/Alias | ATPase6; MTATP6; ATP6; MT-ATP6 |
| Species | Human |
| Gene ID (Human) | 4508 |
| Gene ID | 4508 |
| Immunogen | A synthetic peptide corresponding to a sequence within amino acids 1-100 of human MT-ATP6 (YP_003024031.1). |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, IF/ICC, IHC-P, ELISA |
| Cross Reactivity | Human, Mouse, Rat |
| SWISS | P00846 |
| Protein Weight | 25 kDa |
| Shipping | Ice bag |
Biological Background: MT-ATP6 Function and Localization
- MT-ATP6 encodes the ATP synthase F(0) complex subunit a, also known as F-ATPase protein 6, a core component of complex V of the mitochondrial respiratory chain.
- Subunit a collaborates with subunit c (ATP5MC1) to form the proton-conducting channel in the F(0) domain, driving ATP synthesis via the rotary catalytic mechanism.
- The protein resides in the mitochondrial inner membrane and spans it multiple times, creating two half-channels for proton translocation via a Grotthuss mechanism.
Related references: PMID:37244256 - Mutations in MT-ATP6 are linked to mitochondrial disorders including Leber hereditary optic neuropathy, Leigh syndrome, neuropathy, ataxia, and retinitis pigmentosa (as noted in UniProt disease keywords).
- The protein is highly conserved across human, mouse, and rat, suggesting cross-reactivity potential.
- With a molecular weight of approximately 25 kDa (24817 Da by calculation), it migrates as a discrete band in SDS–PAGE under appropriate conditions.
Experimental Guidance and Technical Tips
- The immunogen targets the N‑terminal 1‑100 amino acid sequence of human MT‑ATP6, which is predicted to face the mitochondrial matrix. Therefore, membrane permeabilization is essential for epitope access in IF/ICC and IHC‑P.
- For Western blotting, a band near 25 kDa is expected. Enrichment of mitochondrial fractions can improve signal‑to‑noise ratio.
- In immunostaining, co‑localization with a mitochondrial marker (e.g., MitoTracker, anti‑ATP5A) is advisable to confirm specificity.
- Antigen retrieval methods (heat‑induced or enzymatic) may be required for formalin‑fixed paraffin‑embedded sections in IHC‑P; test on tissues with abundant mitochondria (heart, skeletal muscle).
- These recommendations are based on immunogen properties and target biology; each laboratory should establish its own optimized protocol.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio is a premier B2B supplier of IVD raw materials, offering this anti‑MT‑ATP6 polyclonal antibody as part of a comprehensive portfolio for mitochondrial disease research and diagnostics. Beyond single antibodies, we provide matched antibody pairs, bulk monoclonals/polyclonals, assay ancillary reagents, and custom sourcing for rare targets. Our expert team supports manufacturers from initial concept through clinical validation, streamlining your path to market.
Product Datasheet
Anti-MT-ATP6 Polyclonal Antibody for WB, IF/ICC, IHC-P, ELISA - P00846
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!